B.R.A.I.N. Biotechnology Research and Information Network stock forecast
Want to see DE:BNN full AI Analyst Report?
B.R.A.I.N. Biotechnology Research and Information Network (BNN) Stock Forecast & Price Target
BNN Analyst Ratings
BNN Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Nicolas Pauillac | Kepler Capital | €5 | buy | 96.08%Upside | Reiterated | 02/25/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Nicolas PauillacKepler Capital | BuyReiterated€5 | 02/25/26 | 96.08%Upside |
Best Analysts Covering B.R.A.I.N. Biotechnology Research and Information Network
Copying Nicolas Pauillac's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +16.71% per trade.
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +4.17% per trade.
Copying Nicolas Pauillac's trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +11.11% per trade.
BNN Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, BNN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. BNN average Analyst price target in the past 3 months is ―.
BNN Financial Forecast
BNN Earnings Forecast
Next quarter’s earnings estimate for BNN is -EUR 0.16 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.16. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
BNN Sales Forecast
Next quarter’s sales forecast for BNN is EUR 11.23M with a range of ― to ―. The previous quarter’s sales results were EUR 11.23M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

